Korean skincare and makeup brands entering the American market must understand K-beauty FDA requirements before shipping a single product. The rules governing cosmetics in the United States changed significantly with the Modernization of Cosmetics Regulation Act of 2022, known as MoCRA, which introduced the most substantial update to US cosmetics oversight in decades. For Korean brands accustomed to their home market’s framework, these federal requirements around registration, labeling, safety substantiation, and adverse event reporting are essential to get right from the start. This guide explains what applies and how to prepare.
How the FDA Regulates Cosmetics
In the United States, cosmetics are regulated by the Food and Drug Administration under laws that historically gave the FDA less pre-market authority over cosmetics than over drugs. Cosmetics generally do not need FDA approval before going to market, but they must be safe when used as intended and properly labeled. The manufacturer and the brand owner bear responsibility for ensuring safety, not the FDA.
A crucial distinction for K-beauty brands is the line between a cosmetic and a drug. A product that only cleanses or beautifies is a cosmetic. But if a product claims to treat or prevent a condition, or to affect the structure or function of the body, it may be classified as a drug and face far stricter requirements. Common examples include sunscreens, anti-acne treatments, and products marketed to lighten skin or reduce wrinkles through active ingredients. Many Korean products blur this line, and marketing claims can unintentionally turn a cosmetic into a regulated drug in the US.
What MoCRA Changed for Cosmetics
MoCRA significantly expanded the FDA’s authority and created new obligations for cosmetic companies. The central changes for a K-beauty FDA strategy include mandatory facility registration, product listing, safety substantiation, adverse event recordkeeping, and new labeling requirements. These shifted cosmetics from a largely voluntary system to one with enforceable federal duties.
Under MoCRA, facilities that manufacture or process cosmetics for the US market generally must register with the FDA and renew that registration periodically. Brand owners, referred to as responsible persons, must list each cosmetic product and its ingredients with the FDA. There is also a requirement to maintain records supporting the safety of each product. For Korean brands that manufacture overseas, this means your manufacturing facility and your product portfolio both come into scope, and a US agent may be needed to interface with the FDA.
Facility Registration and Product Listing
The responsible person and the manufacturing facility have distinct obligations under MoCRA. The facility, even if located in Korea, generally must register with the FDA if its products are distributed in the US. The responsible person, typically the brand owner or importer, must submit product listings that identify each marketed cosmetic and its ingredients. These processes are handled through FDA electronic systems, and there are timelines for initial submissions and renewals.
Some small businesses may qualify for exemptions from certain registration and listing requirements based on revenue thresholds, but these exemptions do not apply to products that pose higher risk, such as those that come into contact with the eye’s mucous membrane, are injected, or are intended for internal use. Because thresholds and categories are specific, Korean brands should confirm whether they qualify for any exemption rather than assuming it. Even exempt companies must still meet safety and labeling obligations.
Labeling, Safety Substantiation, and Fragrance Allergens
US cosmetic labeling has its own rules that differ from Korean requirements. Labels must be in English, include an ingredient declaration using recognized ingredient nomenclature, state the net quantity of contents, and identify the responsible party. MoCRA also introduced requirements around disclosing certain fragrance allergens, with details defined through FDA rulemaking. Getting labeling wrong is one of the most common reasons imported cosmetics are detained at the border.
Safety substantiation is now a formal expectation. The responsible person must maintain records and evidence demonstrating that each product is safe under normal and expected use. This can include ingredient safety data, testing, and toxicological assessments. MoCRA also established mandatory adverse event reporting, meaning serious adverse events must be reported to the FDA within a set timeframe, and the responsible person must keep related records. Korean brands should build a documentation system for safety and adverse events before launch, not after a problem arises.
Practical Steps for K-Beauty Brands Entering the US
Start by auditing your product line to determine whether any items are drugs rather than cosmetics based on their ingredients and claims, since sunscreens and treatment claims are especially common in K-beauty. Next, confirm your manufacturing facility’s registration status and appoint a responsible person and, if needed, a US agent. Prepare compliant English labels, assemble safety substantiation records for each product, and set up an adverse event reporting process. Finally, establish your US business structure, importer of record, and customs procedures so products clear the border smoothly.
Fees and specific requirements vary and evolve as the FDA issues guidance and rules, so treat any cost or threshold as roughly indicative and verify current requirements. Building compliance into your launch plan from day one is far cheaper than facing detained shipments, recalls, or enforcement later.
This article is general information, not legal or regulatory advice. FDA and MoCRA requirements change and vary by product, so consult a qualified regulatory professional before importing or selling cosmetics in the US.
If you are a K-beauty brand planning your US launch and want help with company formation, importer setup, and FDA and MoCRA compliance, our team can guide you through it. Book a free consultation with USdongsan and bring your brand to the US the right way.
Frequently Asked Questions
Does the FDA approve K-beauty cosmetics before I can sell them?
Generally no. Most cosmetics do not require FDA pre-market approval, but they must be safe and properly labeled, and under MoCRA you must register facilities, list products, and keep safety records. Products classified as drugs, such as sunscreens, face stricter, separate requirements.
Do I need to register my Korean factory with the FDA?
In most cases, a facility that manufactures cosmetics distributed in the US must register with the FDA, even if it is located in Korea. Small business exemptions may apply in limited situations, but higher-risk products do not qualify, so confirm your specific status before assuming an exemption.
What makes a K-beauty product a drug instead of a cosmetic?
Claims and active ingredients matter. If a product is intended to treat or prevent a condition or to affect the body’s structure or function, it may be a drug. Sunscreens, anti-acne products, and certain anti-aging or skin-lightening claims commonly cross this line and trigger stricter FDA requirements.
